Search Results - Juying Wei
- Showing 1 - 2 results of 2
-
1
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1–positive B-Cell Lymphoma by Hui Liu, Wen Lei, Chaoting Zhang, Chunmei Yang, Juying Wei, Qunyi Guo, Xiaojun Guo, Zhilu Chen, Ying Lu, Ken H. Young, Zheming Lu, Wenbin Qian
Published 2020Artigo -
2
Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China by De Zhou, Xianbo Huang, Lixia Zhu, Xuelian Hu, Xiudi Yang, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Jingjing Zhu, Shuqi Zhao, Wanzhuo Xie, Hongyan Tong, Jie Jin, Xiujin Ye
Published 2025Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Antigen
Biology
Bone marrow
CD19
CD28
Cancer research
Chemistry
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Dexamethasone
Disease
Gastroenterology
Hemophagocytic lymphohistiocytosis
Immune system
Immunology
Immunotherapy
Lymphoma
Myelofibrosis
PD-L1
Phases of clinical research
Receptor
Regimen
Ruxolitinib
T cell